Eventide Asset Management, LLC 13D and 13G filings for Nektar Therapeutics:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 12:08 pm Sale | 2024-12-31 | 13G | NEKTAR THERAPEUTICS NKTR | Eventide Asset Management, LLC | 443,333 3.610% | -183,334 (-29.26%) | Filing |
| 2024-11-14 12:17 pm Purchase | 2024-09-30 | 13G | NEKTAR THERAPEUTICS NKTR | Eventide Asset Management, LLC | 626,667 5.110% | 626,667 (New Position) | Filing |